← Back to Clinical Trials
Recruiting NCT07044869

NCT07044869 Effects of Facilitated Positional Release Technique ( FPRT) Vs Manual Myofascial Release Technique in Female Patients With Piriformis Syndrome.

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07044869
Status Recruiting
Phase
Sponsor Foundation University Islamabad
Condition Piriformis Syndrome
Study Type INTERVENTIONAL
Enrollment 38 participants
Start Date 2024-07-26
Primary Completion 2025-08-20

Eligibility & Interventions

Sex Female only
Min Age 25 Years
Max Age 50 Years
Study Type INTERVENTIONAL
Interventions
FACILITATED POSITIONAL RELEASE TECHNIQUEMANUAL MYOFASCIAL RELEASE TECHNIQUE

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 38 participants in total. It began in 2024-07-26 with a primary completion date of 2025-08-20.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study is a randomized control trial, and the purpose of this study is to determine the "Effects of Facilitated Positional Release Technique ( FPRT) Vs Manual Myofascial Release Technique in Female Patients with Piriformis Syndrome.

Eligibility Criteria

Inclusion Criteria: * • 25-50 years Only females Diagnosed piriformis syndrome Pain from 2 months Exclusion Criteria: * Lumbar Radiculopathy Fracture trauma to lumbar spine surgery/ total hip replacement hip OA

Contact & Investigator

Central Contact

Fariya Maryam, DPT

✉ fariyamaryam9@gmail.com

📞 +923102541357

Frequently Asked Questions

Who can join the NCT07044869 clinical trial?

This trial is open to female participants only, aged 25 Years or older, up to 50 Years, studying Piriformis Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07044869 currently recruiting?

Yes, NCT07044869 is actively recruiting participants. Contact the research team at fariyamaryam9@gmail.com for enrollment information.

Where is the NCT07044869 trial being conducted?

This trial is being conducted at Islamabad, Pakistan.

Who is sponsoring the NCT07044869 clinical trial?

NCT07044869 is sponsored by Foundation University Islamabad. The trial plans to enroll 38 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology